Milestones in the curability of pediatric cancers.
作者信息
Hudson Melissa M, Link Michael P, Simone Joseph V
机构信息
St Jude Children's Research Hospital, Memphis, TN
Stanford University School of Medicine, Palo Alto, CA.
出版信息
J Clin Oncol. 2014 Aug 10;32(23):2391-7. doi: 10.1200/JCO.2014.55.6571. Epub 2014 Apr 14.
Abstract
摘要
相似文献
1
Milestones in the curability of pediatric cancers.
J Clin Oncol. 2014 Aug 10;32(23):2391-7. doi: 10.1200/JCO.2014.55.6571. Epub 2014 Apr 14.
2
Pediatric Oncologic Emergencies.
Hematol Oncol Clin North Am. 2017 Dec;31(6):959-980. doi: 10.1016/j.hoc.2017.08.003.
3
Beyond survival.
Science. 2019 Mar 15;363(6432):1166-1169. doi: 10.1126/science.363.6432.1166.
4
["Quality of life" of long term survivors of childhood cancer].
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 2):884-6.
5
Childhood cancer: unique opportunities and inherent challenges.
Med J Aust. 2020 Feb;212(3):110-111. doi: 10.5694/mja2.50487. Epub 2020 Jan 25.
6
Oncology. In their prime, and dying of cancer.
Science. 2007 Aug 31;317(5842):1160-2. doi: 10.1126/science.317.5842.1160.
7
Progress in pediatric cancer.
Clin Cancer Res. 2012 May 15;18(10):2734. doi: 10.1158/1078-0432.CCR-12-1014.
8
Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology.
Pediatrics. 1997 Jan;99(1):139-41. doi: 10.1542/peds.99.1.139.
9
Pediatric oncology in Turkey.
J Pediatr Hematol Oncol. 2012 Mar;34 Suppl 1:S12-4. doi: 10.1097/MPH.0b013e318249aaac.
10
Introduction and overview to issue on new developments in pediatric hematology/oncology.
Curr Opin Pediatr. 2013 Feb;25(1):1-2. doi: 10.1097/MOP.0b013e32835c15a0.
引用本文的文献
1
Cancer complexity: why we need a novel cancer research strategy.
Front Oncol. 2025 Aug 1;15:1624467. doi: 10.3389/fonc.2025.1624467. eCollection 2025.
2
Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata.
BMC Public Health. 2024 Dec 30;24(1):3602. doi: 10.1186/s12889-024-21155-8.
3
Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas.
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050704. Epub 2024 Jun 25.
4
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
BMJ Open. 2024 Mar 18;14(3):e077613. doi: 10.1136/bmjopen-2023-077613.
5
ICU Admissions and Outcomes of Childhood Cancer Patients in Single Tertiary Hospital in the Private Sector in India.
South Asian J Cancer. 2022 Sep 2;12(3):286-289. doi: 10.1055/s-0042-1756283. eCollection 2023 Jul.
6
The Greatest Healthcare Disparity: Addressing Inequities in the Treatment of Childhood Central Nervous System Tumors in Low- and Middle-Income Countries.
Adv Tech Stand Neurosurg. 2023;48:1-19. doi: 10.1007/978-3-031-36785-4_1.
7
Fertility preservation in pediatric healthcare: a review.
Front Endocrinol (Lausanne). 2023 May 3;14:1147898. doi: 10.3389/fendo.2023.1147898. eCollection 2023.
8
Improvement of Diet after an Early Nutritional Intervention in Pediatric Oncology.
Children (Basel). 2023 Mar 31;10(4):667. doi: 10.3390/children10040667.
9
Experiences of Female Childhood Cancer Patients and Survivors Regarding Information and Counselling on Gonadotoxicity Risk and Fertility Preservation at Diagnosis: A Systematic Review.
Cancers (Basel). 2023 Mar 23;15(7):1946. doi: 10.3390/cancers15071946.
10
The Health Care Utilization and Medical Costs in Long-Term Follow-Up of Children Diagnosed With Leukemia, Solid Tumor, or Brain Tumor: Population-Based Study Using the National Health Insurance Claims Data.
JMIR Public Health Surveill. 2023 Mar 2;9:e42350. doi: 10.2196/42350.
本文引用的文献
1
Childhood and adolescent cancer statistics, 2014.
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103. doi: 10.3322/caac.21219. Epub 2014 Jan 31.
2
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.
J Clin Oncol. 2014 Mar 1;32(7):647-53. doi: 10.1200/JCO.2013.50.3557. Epub 2014 Jan 27.
3
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.
Pediatr Blood Cancer. 2014 Jun;61(6):1101-3. doi: 10.1002/pbc.24891. Epub 2013 Dec 3.
4
Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies.
J Clin Oncol. 2013 Sep 20;31(27):3378-88. doi: 10.1200/JCO.2012.46.7050. Epub 2013 Aug 19.
5
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Clin Cancer Res. 2013 Aug 1;19(15):4239-48. doi: 10.1158/1078-0432.CCR-13-0071. Epub 2013 Jun 13.
6
Clinical ascertainment of health outcomes among adults treated for childhood cancer.
JAMA. 2013 Jun 12;309(22):2371-2381. doi: 10.1001/jama.2013.6296.
7
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation.
Blood. 2013 Jul 25;122(4):550-3. doi: 10.1182/blood-2013-03-487744. Epub 2013 Jun 6.
8
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
J Clin Oncol. 2013 Jul 1;31(19):2469-76. doi: 10.1200/JCO.2012.47.0500. Epub 2013 May 20.
9
Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.
J Clin Oncol. 2013 Jun 10;31(17):2182-8. doi: 10.1200/JCO.2012.46.7944. Epub 2013 May 6.
10
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Lancet Oncol. 2013 May;14(6):472-80. doi: 10.1016/S1470-2045(13)70095-0. Epub 2013 Apr 16.
Zotero 插件